Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement

NCT05542277 is registered in ClinicalTrials.gov with PlasFree Ltd. as lead sponsor.

NCT NCT05542277
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542277 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pre-market, Multi-center, International, Double-blind, Randomized, Two-arms, Controlled, Prospective Clinical Investigation Assessing the Safety and Performance of a Medical Device (ClearPlasma™) for the Treatment of Patients Undergoing Coronary Artery Bypass or Valve Replacement
Lead sponsor
PlasFree Ltd.
Phase
Not applicable
Overall status
Terminated
Start date
November 8, 2022
Completion date
March 9, 2025
Enrollment
130 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, bypass complication, valve replacement